Reneo Pharmaceuticals, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
RPHM on Nasdaq
Location
18575 Jamboree Road, Suite 275 S, Irvine, California

Insiders trading volume in the past year

Reneo Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Holdings A/S Novo 10%+ Owner $20.9M Jun 23, 2023
Braden M. Leonard 10%+ Owner $5.6M +$1.02M +22.3% Aug 13, 2024
Michael G. Grey Executive Chairman, Director $841K Jul 26, 2023
Gregory J. Flesher President and CEO, Director $723K Dec 9, 2022
Michael Cruse Chief Operating Officer $310K Dec 9, 2022
Ashley Hall Chief Development Officer $249K Aug 28, 2023
Vineet R. Jindal Chief Financial Officer $230K Dec 10, 2021
Alejandro Dorenbaum Chief Medical Officer $188K Dec 9, 2022
Jennifer Lam VP of Finance & Administration $129K Dec 9, 2022
Bali Muralidhar Director Jun 6, 2023
Edward T. Mathers Director Jun 6, 2023
Wendy S. Johnson Chief Development Officer Jul 14, 2021
Eric M. Dube Director Jun 6, 2023
Paul W. Hoelscher Director Jun 6, 2023
Stacey Denenberg Seltzer Director Jun 6, 2023
Niall O'Donnell Director Jun 6, 2023
Roshawn A. Blunt Director Jun 6, 2023
Kenneth Ph.D. Harrison Director Apr 8, 2021

Recent Insider Transactions by Companies or Individuals for Reneo Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.